Literature DB >> 25346300

Grading criteria for disease severity by pemphigus disease area index.

Tomoko Shimizu1, Toru Takebayashi, Yuji Sato, Hironori Niizeki, Yumi Aoyama, Yasuo Kitajima, Keiji Iwatsuki, Takashi Hashimoto, Jun Yamagami, Victoria P Werth, Masayuki Amagai, Akiko Tanikawa.   

Abstract

Pemphigus is a group of autoimmune blistering diseases that affect the skin and mucous membranes. A reliable and accurate disease severity tool to assess pemphigus severity is crucial for managing pemphigus and for clinical trials. The purpose of this study was to compare the pemphigus disease area index activity score (PDAI), the Japanese pemphigus disease severity score (JPDSS) and the physician's subjective impression, and also to find appropriate severity grading cut-offs for the PDAI. We also evaluated the correlation between PDAI activity score and the JPDSS. Thirty-seven pemphigus patients and 110 assessments were analyzed in this study. The optimal points of pemphigus disease severity score in PDAI were: mild (0-8), moderate (9-24) and severe (≥25). In mild or moderate cases, the JPDSS was well correlated with the PDAI, but in severe cases the JPDSS reached a plateau at a PDAI score of approximately 30. The PDAI evaluates disease severity more accurately than the JPDSS, particularly in severe cases. The PDAI is not only a useful tool to measure the extent of cutaneous lesions, but also an excellent scoring system for evaluating pemphigus disease severity.
© 2014 Japanese Dermatological Association.

Entities:  

Keywords:  Japanese pemphigus disease severity score; clinical trial; outcome instrument; pemphigus; pemphigus disease area index; severity index

Mesh:

Year:  2014        PMID: 25346300     DOI: 10.1111/1346-8138.12649

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  12 in total

Review 1.  Pemphigus.

Authors:  Michael Kasperkiewicz; Christoph T Ellebrecht; Hayato Takahashi; Jun Yamagami; Detlef Zillikens; Aimee S Payne; Masayuki Amagai
Journal:  Nat Rev Dis Primers       Date:  2017-05-11       Impact factor: 52.329

2.  Diagnosis and management of pemphigus: Recommendations of an international panel of experts.

Authors:  Dedee F Murrell; Sandra Peña; Pascal Joly; Branka Marinovic; Takashi Hashimoto; Luis A Diaz; Animesh A Sinha; Aimee S Payne; Maryam Daneshpazhooh; Rüdiger Eming; Marcel F Jonkman; Daniel Mimouni; Luca Borradori; Soo-Chan Kim; Jun Yamagami; Julia S Lehman; Marwah Adly Saleh; Donna A Culton; Annette Czernik; John J Zone; David Fivenson; Hideyuki Ujiie; Katarzyna Wozniak; Ayşe Akman-Karakaş; Philippe Bernard; Neil J Korman; Frédéric Caux; Kossara Drenovska; Catherine Prost-Squarcioni; Snejina Vassileva; Ron J Feldman; Adela Rambi Cardones; Johann Bauer; Dimitrios Ioannides; Hana Jedlickova; Francis Palisson; Aikaterini Patsatsi; Soner Uzun; Savas Yayli; Detlef Zillikens; Masayuki Amagai; Michael Hertl; Enno Schmidt; Valeria Aoki; Sergei A Grando; Hiroshi Shimizu; Sharon Baum; Guiseppe Cianchini; Claudio Feliciani; Pilar Iranzo; Jose M Mascaró; Cezary Kowalewski; Russell Hall; Richard Groves; Karen E Harman; M Peter Marinkovich; Emanual Maverakis; Victoria P Werth
Journal:  J Am Acad Dermatol       Date:  2018-02-10       Impact factor: 11.527

3.  The Effect of Low Level Laser Therapy on Pemphigus Vulgaris Lesions: A Pilot Study.

Authors:  Maryam Yousef; Parvin Mansouri; Masoud Partovikia; Mitra Esmaili; Shima Younespour; Ladan Hassani
Journal:  J Lasers Med Sci       Date:  2017-09-27

4.  Establishing cut-off values for mild, moderate and severe disease in patients with pemphigus using the Pemphigus Disease Area Index.

Authors:  R L Krain; C E Bax; S Chakka; S Ahmed; R Feng; A S Payne; V P Werth
Journal:  Br J Dermatol       Date:  2021-02-01       Impact factor: 9.302

5.  Effect of NUDT15 polymorphisms on early hematological safety of low-dose azathioprine in Chinese patients with pemphigus vulgaris: A prospective cohort study.

Authors:  Xingli Zhou; Liangliang Cheng; Yiyi Wang; Hui Gou; Ke Ju; TianJiao Lan; Tongying Zhan; GaoJie Li; Yuanxia Gu; Yeting Sun; Yan Xu; Yukun Sun; Yanhong Zhou; Wei Li
Journal:  J Dermatol       Date:  2021-12-05       Impact factor: 3.468

Review 6.  Validation studies of outcome measures in pemphigus.

Authors:  Sarah Hanna; Minhee Kim; Dedee F Murrell
Journal:  Int J Womens Dermatol       Date:  2016-12-10

7.  Acantholysis may precede elevation of circulating anti-desmoglein 3 antibody levels in pemphigus vulgaris presenting with desquamative gingivitis.

Authors:  Hiroyasu Endo; Terry D Rees; Hideo Niwa; Kayo Kuyama; Maya Oshima; Tae Serizawa; Shigeo Tanaka; Masamichi Komiya; Takanori Ito
Journal:  Clin Exp Dent Res       Date:  2019-03-04

Review 8.  Role of immune cells in the ocular manifestations of pemphigoid diseases.

Authors:  Tanima Bose
Journal:  Ther Adv Ophthalmol       Date:  2019-08-08

9.  Assessing the Correlation Between Disease Severity Indices and Quality of Life Measurement Tools in Pemphigus.

Authors:  Rebecca L Krain; Carolyn J Kushner; Meera Tarazi; Rebecca G Gaffney; Andrea C Yeguez; Danielle E Zamalin; David R Pearson; Rui Feng; Aimee S Payne; Victoria P Werth
Journal:  Front Immunol       Date:  2019-11-06       Impact factor: 7.561

Review 10.  Comparison of Guidelines for Management of Pemphigus: a Review of Systemic Corticosteroids, Rituximab, and Other Immunosuppressive Therapies.

Authors:  Haiqin Zhu; Meng Pan; Wenzhe Zhao; Jingying Wang
Journal:  Clin Rev Allergy Immunol       Date:  2021-08-04       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.